ArticleBMC cancer2025

Telpegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia in patients with high- or medium-risk non-myeloid malignancies: a multicenter, retrospective study.

Yanbing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.